Exploring the protective role of DDIT4/mTOR in podocyte integrity through macrophage polarization in diabetic kidney

Jingxuan Shi1,2, Xiansen Wei1, Guming Zou1

  • 1Department of Nephrology, China-Japan Friendship Hospital, Beijing, China.

Renal Failure
|September 8, 2025
PubMed
Abstract

Insights

DDIT4 regulates macrophage polarization and inflammation via the mTOR pathway, offering a new therapeutic target for diabetic nephropathy. This study shows DDIT4 reduces M1 macrophages and podocyte apoptosis in diabetic kidney disease models.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Diabetic kidney disease (DKD) is characterized by inflammation and renal podocyte injury.
  • Macrophage polarization plays a critical role in DKD pathogenesis.
  • The mTOR signaling pathway is implicated in macrophage function and inflammation.

Purpose of the Study:

  • To investigate the role of DDIT4 in macrophage polarization and inflammation in DKD.
  • To explore DDIT4 as a potential therapeutic target for DKD treatment.

Main Methods:

  • DKD animal model establishment and evaluation using biochemical assays, pathology, and Western blot.
  • Isolation and analysis of podocytes and macrophages from renal tissues.
  • Construction of M1 macrophage and macrophage-podocyte co-culture models to assess DDIT4's effects.
  • Transmission electron microscopy for ultrastructural analysis.

Main Results:

  • DKD model exhibited elevated renal inflammation, podocyte damage, and M1 macrophage infiltration.
  • Overexpression of DDIT4 in M1 macrophages reduced M1 phenotype and inflammatory factor expression.
  • DDIT4 overexpression in co-culture systems decreased podocyte apoptosis and protected podocyte morphology.

Conclusions:

  • DDIT4 effectively mediates macrophage phenotype transformation and reduces inflammation in DKD.
  • DDIT4 presents a promising therapeutic target for DKD intervention.
  • Further research on DDIT4 could lead to novel treatments for unmet clinical needs in DKD.